Tirzepatides 5 mg, 10 mg, and 15 mg doses showed A1C reductions of 2.01, 2.24 and 2.30, respectively, surpassing semaglutides 1.86 reduction at the 1 mg dose
These medications: reduce appetite lower inflammation improve liver fat improve metabolic markers reduce cardiovascular events (SELECT trial) They do not : build muscle increase VO max improve mitochondrial function replace strength training fix metabolic flexibility guarantee long-term weight maintenance 2
If a weight loss medication is on Aetnas formulary, a prior authorization may be required for its coverage
According to Growth Market Reports, the cold-chain biologics market is projected to reach about $39.1 billion by 2033, growing at a compound annual rate of 8.3%
Liraglutide-induced nausea can reduce fluid intake
Cyclic peptides are gaining attention for their improved stability and potential for oral delivery